Author

N. Ultee

Observed name: Nigel Ultee

Institution: The Netherlands Cancer Institute

Observed institution: The Netherlands Cancer Institute

ORCID: 0009-0008-2101-4459

Observed ORCID: 0009-0008-2101-4459

OpenAlex ID: A5117581658

Immunohistochemical biomarkers to predict adjuvant chemotherapy response in patients with early breast cancer in the MATADOR trial (BOOG 2005-02)

2026 · Mark Opdam, Nigel Ultee, et al. · The Breast

3MO Immunohistochemical biomarkers to predict adjuvant chemotherapy response in patients with early breast cancer in the MATADOR trial

2025 · M. Opdam, N. Ultee, et al. · ESMO Open

Works count: 2

Citation count:

H-index:

I10-index: